CG Oncology, Inc.
CGON
$27.03
$1.616.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -104.82% | -96.30% | -93.47% | -94.94% | -- |
| Total Depreciation and Amortization | 957.89% | 225.00% | 100.00% | 125.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -152.94% | -- |
| Total Other Non-Cash Items | 1,526.50% | 2,373.69% | 1,273.76% | -137.64% | -- |
| Change in Net Operating Assets | 803.53% | 328.45% | -19.66% | -74.53% | -- |
| Cash from Operations | -41.80% | -37.94% | -90.11% | -116.44% | -- |
| Capital Expenditure | -720.69% | -1,222.22% | -3,800.00% | -400.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.96% | 32.70% | -680.58% | -170.73% | -- |
| Cash from Investing | 54.89% | 32.61% | -681.06% | -170.74% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 97.86% | 97.82% | -- |
| Issuance of Common Stock | -44.38% | -44.38% | 112,167.85% | 90,972.61% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -99.28% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.17% | 96.13% | 3.85% | -1,373.63% | -- |
| Cash from Financing | -42.39% | -41.09% | 3,297.19% | 906.36% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.13% | -163.05% | 349.90% | 132.17% | -- |